SOLID TUMOR CANCER
Clinical trials for SOLID TUMOR CANCER explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMOR CANCER trials appear
Sign up with your email to follow new studies for SOLID TUMOR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New imaging agent aims to spot Hard-to-Find cancers
Diagnosis TerminatedThis study was designed to test a new imaging agent called 111In-ABD147 that targets a protein (DLL3) found on many solid tumors, including prostate cancer and neuroendocrine tumors. The goal was to see if it could help detect metastatic cancer using SPECT scans. However, the stu…
Matched conditions: SOLID TUMOR CANCER
Phase: EARLY_PHASE1 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated May 22, 2026 14:03 UTC
-
Tissue collection study aims to build smarter cancer test
Knowledge-focused OngoingThis study collects fresh tumor samples from 416 adults with various cancers (bladder, kidney, colorectal, head and neck, liver, lung, skin, endometrial) to develop and train a live tumor diagnostic platform. The goal is to see how accurately the platform can predict whether a pa…
Matched conditions: SOLID TUMOR CANCER
Sponsor: Elephas • Aim: Knowledge-focused
Last updated May 26, 2026 04:01 UTC
-
Gene therapy patients monitored for years in new safety study
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows about 400 adults who previously received A2Bio gene therapy for various solid tumors, including lung, colon, and pancreatic cancers. The main goal is to track long-term safety and see how well the treatment effects last over time. Participants do not receive ne…
Matched conditions: SOLID TUMOR CANCER
Sponsor: A2 Biotherapeutics Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 03:59 UTC
-
New PET scan tracer aims to predict cancer treatment success
Knowledge-focused TerminatedThis study was designed to test a new imaging agent called 68Ga-FAPI-46 in people with solid tumors. The goal was to see if a PET/CT scan using this agent could predict how well a patient's tumor would respond to antibody-based therapy. The study was withdrawn before enrolling an…
Matched conditions: SOLID TUMOR CANCER
Phase: EARLY_PHASE1 • Sponsor: Eben Rosenthal • Aim: Knowledge-focused
Last updated May 18, 2026 11:59 UTC